APF530

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A controlled-release formulation of the 5-hydroxytryptamine 3 (5-HT3) antagonist granisetron, in which granisteron is encapsulated in a biodegradable poly(ortho ester) polymer, with antiemetic activity. Upon subcutaneous administration, APF530 slowly erodes and releases the active ingredient granisetron over a period of approximately 5 days. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in the suppression of nausea and vomiting.

Learn more about APF530

Latest research - APF530

PubMed
Clinical trials

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article APF530 is a stub. If you are familiar with the topic APF530, you can help us. Paid editors welcome!

 

APF530 is part of WikiMD's free ^articles!

^APF530 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available